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Abstract
Background: Neopterin is produced by human macrophages/monocytes when stimulated with interferon-gamma.
Production of neopterin is found in serum, cerebrospinal fluid (CSF) and urine of patients with infections by viruses,
intracellular bacteria and parasites, autoimmune diseases, malignant tumors and patients in allograft rejection
episodes.
Methods: In this study, the level of neopterin was determined in serum samples obtained from patients infected
with Shigella (all four species) and healthy individuals. The study population comprised of 14 patients infected with
Shigella and 14 normal controls. Serum neopterin was measured using an enzyme-linked immunosorbent assay
(ELISA).
Results: The mean of serum neopterin concentration was 36.32 ± 9.71 nmol/L among patients infected with
Shigella and 2.88 ± 0.77 nmol/L in the control group. The mean serum neopterin levels were significantly higher in
the test group as compared to the normal group (p = 0.002).
Conclusion: This study revealed that neopterin was elevated in patients infected with Shigella.
Introduction
Neopterin is produced by human monocytes/macro-
phages upon stimulation with interferon gamma pro-
duced by activated T-lymphocytes and Natural Killer
(NK) cells [1,2]. It is a low molecular weight pteridine
compound and is thought to represent a marker of
immune activation and the proliferation of macrophages
[3]. Change in concentration of neopterin serves as a
valuable indicator of clinical progression of the disease
to severe, acute form [4].
Levels of neopterin are increased in infections caused
by viruses, intracellular bacteria and parasites, autoim-
mune and other inflammatory diseases, malignant
tumors and allograft transplantation [1,2]. Neopterin
levels in serum or urine usually correlate with the clini-
cal course. The level is high early in the infection and it
decreases as soon as antibodies against the pathogen
become detectable [5,6]. Serial measurements of the
level of neopterin in a particular patient may be useful
in monitoring the course of a condition [4]. Levels of
neopterin in body fluids can be determined by high per-
formance liquid chromatography (HPLC), radioimmuno-
assay (RIA) or ELISA.
Shigella spp. is the major cause of bacillary dysentery
worldwide. It is a Gram negative, non-motile, non-
spore-forming rod-shaped bacterium that is highly infec-
tious. Shigella belongs to the family enterobacteriaceae
and it is transmitted via contaminated food and through
fecal-oral route. Annually, worldwide episodes of Shi-
gella have been estimated to be around 164.7 million,
among which 163.2 million episodes occur in developing
countries and are associated with 1.1 million deaths,
mostly among children under 5 years old [7]. Shigellosis
is an invasive disease of the human intestines and is
characterized by passage of frequent small-volume of
loose stool, consisting largely of blood and mucus.
Symptoms of shigellosis include presentation with fever,
abdominal pain and cramps. Early diagnosis of Shigella
is important as it has very low (10 to 100 organisms)
infective dose [8].
As Shigella spp. are intracellular organisms, the aim of
this study was to determine whether neopterin could be
used as a marker of macrophage activation in patients
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infected with this organism. We examine the concentra-
tion of neopterin in healthy individuals and patients
infected with all four Shigella spp. The levels of neop-
terin in serum were determined using ELISA.
Materials and methods
Sera
Sera were collected after informed consents from
patients admitted to the Hospital Universiti Sains
Malaysia, Kubang Kerian, Kelantan, Malaysia. The sera
(n = 28) were from patients with shigellosis confirmed
by stool culture (n = 14) and from healthy individuals
who did not have diarrhea since past six months (n =
14). All the samples were collected from patients and
individuals who did not have any concurrent chronic or
autoimmune diseases. All the collected sera were stored
in -20°C until measurements were carried out.
ELISA procedure
For quantitative determinations of neopterin in serum,
competitive enzyme immunosorbent assay (ELISA) was
used (neopterin ELISA, IBL, Hamburg). The test was
performed according to the protocol from the manufac-
turer. The intensity of the color developed and the
absorbance was found to be inversely proportional to
the amount of neopterin present in the samples. Thus,
the higher the neopterin concentration in the sample,
the lower was the A450 value(s) we obtained. Standards
of 0.00, 1.35, 4.00, 12.00, 37.00 and 111.00 nmol/L were
used to prepare a standard curve. The levels of neop-
terin concentration in the samples were determined
based on the standard curve.
Statistical evaluation
The statistical significance of the data was determined
by the independent Student’s t-test using SPSS version
15 (SPSS Inc., USA). The differences between the
groups were taken as statistically significant when p <
0.05.
Results and Discussion
Our observations as depicted in Figure 1 reveal concen-
trations of neopterin in patient sera infected with Shi-
gella and their comparison with healthy individuals. In
infected patients, the concentration of neopterin
obtained in this study was >10 nmol/L whereas in
healthy individuals, the concentration of neopterin was
< 10 nmol/L. The mean concentration of serum neop-
terin levels were found to be 36.32 ± 9.71 nmol/L in
patients infected with Shigella as compared to 2.88 ±
0.77 nmol/L in the control group. Serum neopterin
levels were significantly elevated in patients with shigel-
losis compared to the control group (p = 0.002)
Previous studies indicated that neopterin levels can be
detected in morbidities such as lung infections, HIV
infection, hepatitis B infection, sarcoidosis as well as in
others chronic diseases [1,5,9-11]. To date, there is no
published report describing elevated levels of neopterin
in shigellosis or any other acute diarrheal diseases. In
this study, serum neopterin levels were found to be
significantly higher in patients infected with Shigella
compared to healthy individuals. The results of this
study are comparable to the previous studies in which
the levels of neopterin were elevated in patients infected
with intracellular pathogens (> 10 nmol/L) compared to
healthy individuals (< 10 nmol/L) [1]. As Shigella is an
intracellular pathogen, the cellular immune system
would be activated and immunological processes could
have been triggered by endotoxins produced by Gram
negative bacteria. Consequently, the activation of
T-lymphocytes and formation of INF-gamma could
increase the concentration of neopterin in body fluids.
Previous studies have shown that highest concentra-
tions of neopterin in body fluids were detected in cases
of septic complications and due to LPS from Gram
negative bacteria [12]. The important aspect of our
study was the discriminating ability of neopterin detec-
tion between patients infected with Shigella and healthy
individuals. Despite the fact that neopterin was detected
in the control serum, their levels were still lower com-
pared to the lowest level of neopterin in shigellosis
patient’s serum. We believe that this is the first report
describing significant increase of neopterin in patients
infected with Shigella compared to healthy individuals.
The obvious limitation of this study is due to the rela-
tively small size of the patient population investigated.
Nonetheless, our study should be seen as the first obser-
vation that suggests the use of serum neopterin levels as
a possible, clinical level, surrogate marker of shigellosis.
Figure 1 Serum concentration of neopterin in healthy
individuals (n = 14) and patients infected with Shigella (n = 14)
using ELISA test (p = 0.02).
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